Paper436006
Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney.
Welbourne TC. Can J Biochem, 1979. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Papers, record 436006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/436006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ammonia | Major topic |
| Glutamine | Major topic |
| Glutathione | Major topic |
| Kidney | Major topic |
| Animals | |
| Glycylglycine | |
| Male | |
| Rats |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42151501 | Solute carrier transporters as metabolic gatekeepers in tumor-microenvironment crosstalk. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42151501 | PubMed |
| 41793192 | Glutamine Deprivation Triggers Tribbles Homolog 3 Dependent G-Quadruplex Resolution to Maintain DNA Repair and Tumor Survival. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41793192 | PubMed |
| 41501789 | Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41501789 | PubMed |
| 40571788 | Metabolites as agents and targets for cancer immunotherapy. | Nat Rev Drug Discov | 2025 | https://conductscience.org/library/papers/40571788 | PubMed |
| 38898113 | AMPK targets PDZD8 to trigger carbon source shift from glucose to glutamine. | Cell Res | 2024 | https://conductscience.org/library/papers/38898113 | PubMed |
| 38459595 | A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/38459595 | PubMed |
| 37776396 | Glutamine Defended the Kidneys Versus Lead Intoxication Via Elevating Endogenous Antioxidants, Reducing Inflammation and Carbonyl Stress, as well as Improving Insulin Resistance and Dyslipidemia. | Biol Trace Elem Res | 2024 | https://conductscience.org/library/papers/37776396 | PubMed |
| 37761958 | Alpha-Ketoglutarate Regulates Tnfrsf12a/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37761958 | PubMed |
| 37573361 | Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37573361 | PubMed |
| 36358516 | Maternal Amino Acid Mixtures Supplementation during Late Gestation and Lactation Improved Growth Performance of Piglets through Improving Colostrum Composition and Antioxidant Capacity. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36358516 | PubMed |
| 36316602 | Targeting RAS mutants in malignancies: successes, failures, and reasons for hope. | Cancer Commun (Lond) | 2023 | https://conductscience.org/library/papers/36316602 | PubMed |
| 36077501 | Hormone-Glutamine Metabolism: A Critical Regulatory Axis in Endocrine-Related Cancers. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077501 | PubMed |
| 35897036 | Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment. | Cell Commun Signal | 2022 | https://conductscience.org/library/papers/35897036 | PubMed |
| 34811508 | Metabolic stress induces GD2+ cancer stem cell-like phenotype in triple-negative breast cancer. | Br J Cancer | 2022 | https://conductscience.org/library/papers/34811508 | PubMed |
| 34564407 | A Unique Urinary Metabolic Feature for the Determination of Bladder Cancer, Prostate Cancer, and Renal Cell Carcinoma. | Metabolites | 2021 | https://conductscience.org/library/papers/34564407 | PubMed |
| 33762340 | LncRNA GIRGL drives CAPRIN1-mediated phase separation to suppress glutaminase-1 translation under glutamine deprivation. | Sci Adv | 2021 | https://conductscience.org/library/papers/33762340 | PubMed |
| 32943735 | Glutamine reliance in cell metabolism. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/32943735 | PubMed |
| 32859605 | Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers. | Cancer Res | 2020 | https://conductscience.org/library/papers/32859605 | PubMed |
| 32021249 | Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/32021249 | PubMed |
| 31202359 | Immunometabolism: A new target for improving cancer immunotherapy. | Adv Cancer Res | 2019 | https://conductscience.org/library/papers/31202359 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/436006
GET https://conductscience.org/api/papers/v1/436006/cited_by?page=2